A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

<p>Abstract</p> <p>Background</p> <p>Sixteen melanoma patients (1 stage IIC, 8 stage III, and 7 stage IV) were treated in a Phase I study with a vaccine (DC/Apo-Nec) composed of autologous dendritic cells (DCs) loaded with a mixture of apoptotic/necrotic allogeneic mela...

Full description

Bibliographic Details
Main Authors: von Euw Erika M, Barrio María M, Furman David, Levy Estrella M, Bianchini Michele, Peguillet Isabelle, Lantz Olivier, Vellice Alejandra, Kohan Abraham, Chacón Matías, Yee Cassian, Wainstok Rosa, Mordoh José
Format: Article
Language:English
Published: BMC 2008-01-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/6/1/6

Internet

http://www.translational-medicine.com/content/6/1/6

Similar Items